Sibelium
Sibelium

1.17
Used to address neurological conditions, this generic medicine reduces the frequency of migraine attacks by stabilising calcium channels in blood vessels.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Flunarizine
Reference Brand
Flunarizine
Product Origin
Generic Alternative
Reference Manufacturer
Janssen
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Non-Selective Calcium Channel Blocker
Pharmacological Class
Cerebral Vasodilator
Manufacturer Description
Utilized to manage cerebral blood flow to alleviate migraine frequency and support physical balance.
Mechanism of Action
Blocks transmembrane calcium influx in central smooth muscle cells, preventing arterial spasm and sensory hyperarousal.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Depression, Parkinson's disease, Uncontrolled extrapyramidal disorders
Severe Adverse Events
Extrapyramidal symptoms — requires immediate medical attention, Severe depressive episodes — requires immediate medical attention
Common Side Effects
Drowsiness, Increased appetite, Nausea
Uncommon Side Effects
Weight gain, Fatigue, Dry mouth
Drug Interactions
Alcohol, CNS Depressants, Oral Contraceptives
Pregnancy Safety Warnings
TGA Category C: Safety not verified. Avoid in pregnancy. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Sibelium is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to access Antiretroviral Medication - Tenofovir HIV PrEP Medication